Sodium Oxybate in the Treatment of Alcohol Withdrawal Syndrome: A Randomized Double-Blind Comparative Study versus Oxazepam. The GATE 1 Trial

GHB receptor targets in the CNS: Focus on high-affinity binding sites

(2013) Tina Bay et al.   BIOCHEMICAL PHARMACOLOGY

Sodium Oxybate: A Review of Its Use in Alcohol Withdrawal Syndrome and in the Maintenance of Abstinence in Alcohol Dependence

(2013) Gillian M. Keating   CLINICAL DRUG INVESTIGATION

Sodium oxybate in the treatment of alcohol dependence: from the alcohol withdrawal syndrome to the alcohol relapse prevention

(2013) Katrin Skala et al.   EXPERT OPINION ON PHARMACOTHERAPY

Toxicological analysis of blood and urine samples from female victims of alleged sexual assault

(2012) Alan W. Jones et al.   CLINICAL TOXICOLOGY

The clinical toxicology of gamma-hydroxybutyrate, gamma-butyrolactone and 1,4-butanediol

(2012) Leo J Schep et al.   CLINICAL TOXICOLOGY

Novel Therapeutic Strategies for Alcohol and Drug Addiction: Focus on GABA, Ion Channels and Transcranial Magnetic Stimulation

(2011) Giovanni Addolorato et al.   NEUROPSYCHOPHARMACOLOGY

Case series of 226 γ-hydroxybutyrate–associated deaths: lethal toxicity and trauma

(2010) Deborah L. Zvosec et al.   AMERICAN JOURNAL OF EMERGENCY MEDICINE

Review: The involvement of gamma-hydroxybutyrate in reported sexual assaults: a systematic review

(2010) Zsófia Németh et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Neural bases for addictive properties of benzodiazepines

(2010) Kelly R. Tan et al.   NATURE

The therapeutic potential of gamma-hydroxybutyric acid for alcohol dependence: balancing the risks and benefits. A focus on clinical data

(2009) Giovanni Addolorato et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Alcohol-use disorders

(2009) Marc A Schuckit   LANCET

Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders

(2009) Jürgen Rehm et al.   LANCET

Cognitive, psychomotor, and subjective effects of sodium oxybate and triazolam in healthy volunteers

(2009) Lawrence P. Carter et al.   PSYCHOPHARMACOLOGY

The concentration of oxazepam and oxazepam glucuronide in oral fluid, blood and serum after controlled administration of 15 and 30 mg oxazepam

(2008) Beitske E. Smink et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

New developments for the pharmacological treatment of alcohol withdrawal syndrome. A focus on non-benzodiazepine GABAergic medications

(2007) Lorenzo Leggio et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY